SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hui Wang, Jian Chen, Jiajun Ying, Yuhong Xu, Ruilong Sheng, Hydrophobic chain modified low molecular weight polyethylenimine for efficient antigen delivery, RSC Adv., 2016, 6, 17, 13636

    CrossRef

  2. 2
    Sergey Vital’evich Sennikov, Julia Alexandrovna Shevchenko, Vasilii Vasil’evich Kurilin, Julia Nikolaevna Khantakova, Julia Anatol’evna Lopatnikova, Elena Vasil’evna Gavrilova, Rinat Amirovich Maksyutov, Anastasiya Yur’evna Bakulina, Sergey Vasil’evich Sidorov, Alexander Alexandrovich Khristin, Amir Zakievich Maksyutov, Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients, Immunologic Research, 2016, 64, 1, 171

    CrossRef

  3. 3
    Rodney A. Rosalia, Luis J. Cruz, Suzanne van Duikeren, Angelino T. Tromp, Ana L. Silva, Wim Jiskoot, Tanja de Gruijl, Clemens Löwik, Jaap Oostendorp, Sjoerd H. van der Burg, Ferry Ossendorp, CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses, Biomaterials, 2015, 40, 88

    CrossRef

  4. 4
    P. Leone, S. Berardi, M. A. Frassanito, R. Ria, V. De Re, S. Cicco, S. Battaglia, P. Ditonno, F. Dammacco, A. Vacca, V. Racanelli, Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing, Blood, 2015, 126, 12, 1443

    CrossRef

  5. 5
    Maria A. Clavijo-Salomon, Rodrigo N. Ramos, Alexandre Crippa, Celia R. Pizzo, Patricia C. Bergami-Santos, Jose Alexandre M. Barbuto, Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon?, Cancer Immunology, Immunotherapy, 2015, 64, 2, 161

    CrossRef

  6. 6
    Tiziana Cotechini, Terry R. Medler, Lisa M. Coussens, Myeloid Cells as Targets for Therapy in Solid Tumors, The Cancer Journal, 2015, 21, 4, 343

    CrossRef

  7. 7
    Hila Confino, Ilan Hochman, Margalit Efrati, Michael Schmidt, Viktor Umansky, Itzhak Kelson, Yona Keisari, Tumor ablation by intratumoral Ra-224-loaded wires induces anti-tumor immunity against experimental metastatic tumors, Cancer Immunology, Immunotherapy, 2015, 64, 2, 191

    CrossRef

  8. 8
    Matjaz Humar, Marc Azemar, Martina Maurer, Bernd Groner, Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells, Frontiers in Oncology, 2014, 4,

    CrossRef

  9. 9
    Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro, Antigen-specific vaccines for cancer treatment, Human Vaccines & Immunotherapeutics, 2014, 10, 11, 3332

    CrossRef

  10. 10
    Songwei Tan, Tetsuro Sasada, Anna Bershteyn, Kunyu Yang, Tetsuya Ioji, Zhiping Zhang, Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy, Nanomedicine, 2014, 9, 5, 635

    CrossRef

  11. 11
    Shasha Song, Pingfan Yuan, Huaxun Wu, Jingyu Chen, Jingjing Fu, Peipei Li, Jingtao Lu, Wei Wei, Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells, International Immunopharmacology, 2014, 20, 1, 117

    CrossRef

  12. 12
    Shasha Song, Pingfan Yuan, Peipei Li, Huaxun Wu, Jingtao Lu, Wei Wei, Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma, International Immunopharmacology, 2014, 22, 2, 392

    CrossRef

  13. 13
    Gabriela Piñón-Zárate, Miguel Ángel Herrera-Enríquez, Beatriz Hernández-Téllez, Katia Jarquín-Yáñez, Andrés Eliú Castell-Rodríguez, GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  14. 14
    Valerie Adam, Isabelle Wauters, Johan Vansteenkiste, Melanoma-associated antigen-A3 vaccination in the treatment of non-small-cell lung cancer, Expert Opinion on Biological Therapy, 2014, 14, 3, 365

    CrossRef

  15. 15
    Elham Mohit, Sima Rafati, Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity, Molecular Immunology, 2013, 56, 4, 599

    CrossRef

  16. 16
    D. H. Yi, S. Appel, Current Status and Future Perspectives of Dendritic Cell–Based Cancer Immunotherapy, Scandinavian Journal of Immunology, 2013, 78, 2
  17. 17
    Shisheng Chen, Rongying Ou, Jun Tang, Xiufang Deng, Yuzhang Wu, Jennifer C. van Velkinburgh, Bing Ni, Yunsheng Xu, Enhanced anti-tumor effects of HPV16E749–57-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150, Cancer Epidemiology, 2013, 37, 2, 172

    CrossRef

  18. 18
    Hidenori Takahashi, Masato Okamoto, Shigetaka Shimodaira, Shun-ichi Tsujitani, Masaki Nagaya, Takefumi Ishidao, Junji Kishimoto, Yoshikazu Yonemitsu, Impact of dendritic cell vaccines pulsed with Wilms’ tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers, European Journal of Cancer, 2013, 49, 4, 852

    CrossRef

  19. 19
    Mehdi Ghasemi, Murat Erturk, Kurtulus Buruk, Mehmet Sonmez, Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells, Cytotherapy, 2013, 15, 3, 352

    CrossRef

  20. 20
    Hong Yu, Daniel Sze, William Cho, MicroRNAs Involved in Anti-Tumour Immunity, International Journal of Molecular Sciences, 2013, 14, 3, 5587

    CrossRef

  21. 21
    Michael A. Morse, Arvind Chaudhry, Elizabeth S. Gabitzsch, Amy C. Hobeika, Takuya Osada, Timothy M. Clay, Andrea Amalfitano, Bruce K. Burnett, Gayathri R. Devi, David S. Hsu, Younong Xu, Stephanie Balcaitis, Rajesh Dua, Susan Nguyen, Joseph P. Balint, Frank R. Jones, H. Kim Lyerly, Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients, Cancer Immunology, Immunotherapy, 2013, 62, 8, 1293

    CrossRef

  22. 22
    Xiao Dong Gai, Yang Song, Chun Li, Yan Ming Lei, Baoxue Yang, Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node, Pathology - Research and Practice, 2013, 209, 12, 774

    CrossRef

  23. 23
    Viskam Wijewardana, Kikuya Sugiura, Mana Yahata, Takashi Akazawa, Daluthgamage Patsy H. Wijesekera, Shigeki Imamoto, Shingo Hatoya, Norimitsu Inoue, Toshio Inaba, Production of canine soluble CD40 ligand to induce maturation of monocyte derived dendritic cells for cancer immunotherapy, Veterinary Immunology and Immunopathology, 2013, 156, 1-2, 121

    CrossRef

  24. 24
    Kyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, Pinelopi Samara, Hubert Kalbacher, Wolfgang Voelter, Ioannis P Trougakos, Graham Pawelec, Ourania E Tsitsilonis, Prothymosin α and a prothymosin α-derived peptide enhance TH1-type immune responses against defined HER-2/neu epitopes, BMC Immunology, 2013, 14, 1, 43

    CrossRef

  25. 25
    Seung Joo Kang, Jung Mogg Kim, Seong-Joon Koh, Su Hyun Kim, Jong Pil Im, Hyun Chae Jung, Joo Sung Kim, The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice, Life Sciences, 2013, 92, 22, 1064

    CrossRef

  26. 26
    Renato B. Baleeiro, Karl-Heinz Wiesmüller, Yoran Reiter, Barbara Baude, Lars Dähne, Alexa Patzelt, Jürgen Lademann, José A. Barbuto, Peter Walden, Topical Vaccination with Functionalized Particles Targeting Dendritic Cells, Journal of Investigative Dermatology, 2013, 133, 8, 1933

    CrossRef

  27. 27
    Benedetto Farsaci, Peter Kim, James Hodge, Claudia Palena, James Gulley, Jeffrey Schlom, Targeted Therapies in Oncology, Second Edition, 2013,

    CrossRef

  28. 28
    Seong Loong Lo, Shixiong Lua, Jianxing Song, Shu Wang, A β-sheet structure interacting peptide for intracellular protein delivery into human pluripotent stem cells and their derivatives, Biochemical and Biophysical Research Communications, 2012, 421, 3, 616

    CrossRef

  29. 29
    Riguel J. Inaoka, Achim A. Jungbluth, Sacha Gnjatic, Erika Ritter, Nicole C. Hanson, Denise Frosina, Jodie Tassello, Leina Y. Etto, Adriana B. Bortoluzzo, Antonio C. Alves, Gisele W. B. Colleoni, Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients, Cancer Immunology, Immunotherapy, 2012, 61, 12, 2207

    CrossRef

  30. 30
    Benjamin Frey, Christina Stache, Yvonne Rubner, Nina Werthmöller, Kathrin Schulz, Renate Sieber, Sabine Semrau, Franz Rödel, Rainer Fietkau, Udo S. Gaipl, Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation canin vitroinduce tumor cell death forms with immunogenic potential, Journal of Immunotoxicology, 2012, 9, 3, 301

    CrossRef

  31. 31
    Mallika Tewari, Shipra Sahai, Raghvendra R. Mishra, Sunit K. Shukla, Hari S. Shukla, Dendritic cell therapy in advanced gastric cancer: A promising new hope?, Surgical Oncology, 2012, 21, 3, 164

    CrossRef

  32. 32
    Jacek Tabarkiewicz, Dendritic cells: active and passive players in therapy of human diseases, Immunotherapy, 2012, 4, 10, 975

    CrossRef

  33. 33
    Tomoaki Kurosaki, Takashi Kitahara, Tadahiro Nakamura, Koyo Nishida, Shintaro Fumoto, Yukinobu Kodama, Hiroo Nakagawa, Norihide Higuchi, Hitoshi Sasaki, Development of Effective Cancer Vaccine Using Targeting System of Antigen Protein to APCs, Pharmaceutical Research, 2012, 29, 2, 483

    CrossRef

  34. 34
    Hironori Yoshino, Ikuo Kashiwakura, Impairment of Mature Dendritic Cells Derived from X-Irradiated Human Monocytes Depends on the Type of Maturation Stimulus Used, Radiation Research, 2012, 178, 4, 280

    CrossRef

  35. 35
    An M. T. Van Nuffel, Daphné Benteyn, Sofie Wilgenhof, Jurgen Corthals, Carlo Heirman, Bart Neyns, Kris Thielemans, Aude Bonehill, Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient, Cancer Immunology, Immunotherapy, 2012, 61, 7, 1033

    CrossRef

  36. You have full text access to this Open Access content36
    Ken S. Rosenthal, Patricia Taylor, Daniel H. Zimmerman, J-LEAPS peptide and LEAPS dendritic cell vaccines, Microbial Biotechnology, 2012, 5, 2
  37. 37
    Jose-Ignacio Arias, Maria-Angeles Aller, Isabel Prieto, Ana Arias, Zoe de Julian, Heping Yang, Jaime Arias, The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks, Journal of Oncology, 2012, 2012, 1

    CrossRef

  38. 38
    Bin Bao, Archana Thakur, Yiwei Li, Aamir Ahmad, Asfar S. Azmi, Sanjeev Banerjee, Dejuan Kong, Shadan Ali, Lawrence G. Lum, Fazlul H. Sarkar, The immunological contribution of NF-κB within the tumor microenvironment: A potential protective role of zinc as an anti-tumor agent, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1825, 2, 160

    CrossRef

  39. 39
    Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin, Michael R. Shurin, Tumor associated regulatory dendritic cells, Seminars in Cancer Biology, 2012, 22, 4, 298

    CrossRef

  40. 40
    Andrea Kiessling, Rebekka Wehner, Susanne Füssel, Michael Bachmann, Manfred P. Wirth, Marc Schmitz, Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer, Cancers, 2012, 4, 4, 193

    CrossRef

  41. 41
    Shuxia Song, Yue Wang, Junxia Wang, Weiguang Lian, Shufeng Liu, Zhengzheng Zhang, Fuying Liu, Lin Wei, Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs, European Journal of Cancer, 2012, 48, 14, 2252

    CrossRef

  42. 42
    Tommaso De Pas, Monica Giovannini, Maria Rescigno, Chiara Catania, Francesca Toffalorio, Gianluca Spitaleri, Angelo Delmonte, Massimo Barberis, Lorenzo Spaggiari, Piergiorgio Solli, Giulia Veronesi, Filippo De Braud, Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials, Critical Reviews in Oncology/Hematology, 2012, 83, 3, 432

    CrossRef

  43. 43
    Xizhong Zhang, Sonali N. de Chickera, Christy Willert, Vasliki Economopoulos, Jennifer Noad, Roja Rohani, Adele Y. Wang, Megan K. Levings, Elizabeth Scheid, Ronan Foley, Paula J. Foster, Gregory A. Dekaban, Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model, Cytotherapy, 2011, 13, 10, 1234

    CrossRef

  44. 44
    Phillip D. Fromm, David Gottlieb, Kenneth F. Bradstock, Derek N.J. Hart, Cellular therapy to treat haematological and other malignancies: progress and pitfalls, Pathology, 2011, 43, 6, 605

    CrossRef

  45. 45
    Nathalie Cools, Annacarmen Petrizzo, Evelien Smits, Franco M Buonaguro, Maria L Tornesello, Zwi Berneman, Luigi Buonaguro, Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?, Immunotherapy, 2011, 3, 10, 1203

    CrossRef

  46. 46
    Ya Ting Wang, WenSheng Li, QinShe Liu, XiaoYing Guan, Jun Hu, Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-γ, Experimental and Molecular Pathology, 2011, 91, 1, 325

    CrossRef

  47. 47
    Gregor Eisenwort, Jennifer Jurkin, Nighat Yasmin, Thomas Bauer, Bernhard Gesslbauer, Herbert Strobl, Identification of TROP2 (TACSTD2), an EpCAM-Like Molecule, as a Specific Marker for TGF-β1-Dependent Human Epidermal Langerhans Cells, Journal of Investigative Dermatology, 2011, 131, 10, 2049

    CrossRef

  48. You have free access to this content48
    U. Andersson, K. J. Tracey, Molecular basis of applied biological therapeutics, Journal of Internal Medicine, 2011, 269, 1
  49. 49
    Judith Leibovici, Orit Itzhaki, Monica Huszar, Judith Sinai, Targeting the tumor microenvironment by immunotherapy: part 2, Immunotherapy, 2011, 3, 11, 1385

    CrossRef

  50. 50
    Sharon Veenbergen, Annemiek B. van Spriel, Tetraspanins in the immune response against cancer, Immunology Letters, 2011, 138, 2, 129

    CrossRef

  51. 51
    Cristian Speil, Robert Rzepka, Vaccines and Vaccine Adjuvants as Biological Response Modifiers, Infectious Disease Clinics of North America, 2011, 25, 4, 755

    CrossRef

  52. 52
    Camilo Colaco, Warheads and avoiding Star Wars, EMBO reports, 2011, 12, 5